Alembic Pharmaceuticals’ arm recalls 82,400 bottles of Tobramycin Ophthalmic Solution in US

21 Aug 2023 Evaluate

Alembic Pharmaceuticals’ US-based subsidiary is recalling 82,400 bottles of Tobramycin Ophthalmic Solution in the American market. Tobramycin Ophthalmic Solution is used to treat bacterial infections of the eye.

New Jersey-based Alembic Pharmaceuticals Inc is recalling the affected lot (0.3 per cent, 5ml bottle) due to ‘Failed Impurities/Degradation Specifications’. The company initiated the Class III voluntary recall on July 27 this year. As per USFDA, a Class III recall is initiated in a ‘situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences’.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

965.05 5.00 (0.52%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.